SG11202009295YA - Treatment and prophylaxis of amyloidosis - Google Patents

Treatment and prophylaxis of amyloidosis

Info

Publication number
SG11202009295YA
SG11202009295YA SG11202009295YA SG11202009295YA SG11202009295YA SG 11202009295Y A SG11202009295Y A SG 11202009295YA SG 11202009295Y A SG11202009295Y A SG 11202009295YA SG 11202009295Y A SG11202009295Y A SG 11202009295YA SG 11202009295Y A SG11202009295Y A SG 11202009295YA
Authority
SG
Singapore
Prior art keywords
antibody
seq
concentration
set forth
amino acid
Prior art date
Application number
SG11202009295YA
Other languages
English (en)
Inventor
Tarlochan Nijjar
Iii Philip J Dolan
Robin Barbour
Original Assignee
Prothena Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prothena Biosciences Ltd filed Critical Prothena Biosciences Ltd
Publication of SG11202009295YA publication Critical patent/SG11202009295YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202009295YA 2018-03-23 2019-03-22 Treatment and prophylaxis of amyloidosis SG11202009295YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862647341P 2018-03-23 2018-03-23
PCT/US2019/023528 WO2019183448A1 (en) 2018-03-23 2019-03-22 Treatment and prophylaxis of amyloidosis

Publications (1)

Publication Number Publication Date
SG11202009295YA true SG11202009295YA (en) 2020-10-29

Family

ID=66041747

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009295YA SG11202009295YA (en) 2018-03-23 2019-03-22 Treatment and prophylaxis of amyloidosis

Country Status (13)

Country Link
US (1) US20210017278A1 (cg-RX-API-DMAC7.html)
EP (1) EP3768311A1 (cg-RX-API-DMAC7.html)
JP (1) JP7217287B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200143400A (cg-RX-API-DMAC7.html)
CN (1) CN112040983A (cg-RX-API-DMAC7.html)
AU (2) AU2019240413A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020019172A2 (cg-RX-API-DMAC7.html)
CA (1) CA3095100A1 (cg-RX-API-DMAC7.html)
EA (1) EA202092264A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020009920A (cg-RX-API-DMAC7.html)
MY (1) MY203432A (cg-RX-API-DMAC7.html)
SG (1) SG11202009295YA (cg-RX-API-DMAC7.html)
WO (1) WO2019183448A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009086539A2 (en) * 2007-12-28 2009-07-09 Elan Pharmaceuticals, Inc. Treatment and prophylaxis of amyloidosis
BR112014009866A2 (pt) * 2011-10-25 2018-09-04 Onclave Therapeutics Limited formulações de anticorpos e métodos
RS63446B1 (sr) * 2016-06-30 2022-08-31 Prothena Biosciences Ltd Kompozicije za lečenje amiloidoze

Also Published As

Publication number Publication date
EA202092264A1 (ru) 2020-12-03
KR20200143400A (ko) 2020-12-23
EP3768311A1 (en) 2021-01-27
AU2019240413A1 (en) 2020-10-08
AU2023202109A1 (en) 2023-05-18
MX2020009920A (es) 2020-12-10
CN112040983A (zh) 2020-12-04
JP7217287B2 (ja) 2023-02-02
WO2019183448A1 (en) 2019-09-26
BR112020019172A2 (pt) 2021-01-26
US20210017278A1 (en) 2021-01-21
MY203432A (en) 2024-06-27
JP2021518393A (ja) 2021-08-02
CA3095100A1 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
SG10202101986UA (en) Tetracycline compounds and methods of treatment
GB201804514D0 (en) Treatment of pyroptosis
IL275626A (en) Preparations and methods for surface treatment
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
IL278978A (en) Preparations and methods for treating eczema
ZA202103977B (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
IL276135A (en) Preparations and methods of use
ZA202100780B (en) Bismuth-thiol compositions and methods of use
GB2596661B (en) Therapeutic and prophylactic use of microorganisms
ZA201903795B (en) Treatment of water
IL290983A (en) Treatment methods
GB201804515D0 (en) Treatment of necroptosis
GB201916428D0 (en) Treatment of hydro-carbon-contaminated materials
GB201907305D0 (en) Treatment of conditions
IL276905A (en) Treatment and prevention of preeclampsia
GB201918853D0 (en) Methods of treatment
PT3781172T (pt) Tratamento da pneumonia
GB201810923D0 (en) Compositions and method of treatment
GB2590245B (en) Encapsulated antimicrobials and related methods of treatment
HK40051916A (zh) 淀粉样变性的治疗和预防
GB201912490D0 (en) Treatment of obesity and related conditions
GB201710491D0 (en) Composition and methods of treatment
GB201815000D0 (en) Treatment of hypothroidism and related conditions
GB201810925D0 (en) Compositions and methods of treatment
GB201816914D0 (en) Treatment of inflammation